ValuEngine upgraded shares of Marrone Bio Innovations (NASDAQ:MBII) from a strong sell rating to a sell rating in a research report released on Friday.
Separately, HC Wainwright set a $4.00 target price on Marrone Bio Innovations and gave the stock a buy rating in a report on Thursday, December 21st. One analyst has rated the stock with a sell rating, three have issued a hold rating and one has given a buy rating to the stock. The stock has an average rating of Hold and a consensus target price of $2.50.
Shares of Marrone Bio Innovations (NASDAQ MBII) opened at $1.02 on Friday. The company has a debt-to-equity ratio of -1.14, a quick ratio of 0.36 and a current ratio of 0.69. Marrone Bio Innovations has a twelve month low of $0.85 and a twelve month high of $2.30.
Marrone Bio Innovations (NASDAQ:MBII) last released its quarterly earnings data on Monday, November 13th. The basic materials company reported ($0.27) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.24) by ($0.03). equities analysts anticipate that Marrone Bio Innovations will post -1.01 earnings per share for the current year.
An institutional investor recently raised its position in Marrone Bio Innovations stock. Ardsley Advisory Partners boosted its stake in shares of Marrone Bio Innovations Inc (NASDAQ:MBII) by 375.4% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 3,681,580 shares of the basic materials company’s stock after buying an additional 2,907,142 shares during the quarter. Ardsley Advisory Partners owned approximately 11.74% of Marrone Bio Innovations worth $4,528,000 as of its most recent SEC filing. 37.59% of the stock is currently owned by institutional investors.
TRADEMARK VIOLATION NOTICE: “Marrone Bio Innovations (MBII) Raised to Sell at ValuEngine” was published by Stock Observer and is the property of of Stock Observer. If you are accessing this report on another site, it was illegally copied and republished in violation of US and international trademark and copyright laws. The original version of this report can be accessed at https://www.thestockobserver.com/2018/02/06/marrone-bio-innovations-mbii-raised-to-sell-at-valuengine.html.
Marrone Bio Innovations Company Profile
Marrone Bio Innovations, Inc offers bio-based pest management and plant health products. The Company’s bio-based products include naturally occurring microorganisms, such as bacteria, fungi and plant extracts. It sells its products to crop protection market. Its four crop protection products include Regalia, Grandevo, Venerate and Majestene.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Marrone Bio Innovations Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marrone Bio Innovations and related companies with MarketBeat.com's FREE daily email newsletter.